Radiant(TM) Study is the First Controlled Phase II Trial to Investigate the Efficacy of Human Neural Stem Cells for the Treatment of Dry AMD NEWARK, Calif., July 20, 2015 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the brain, eye […]

Leer Más "RADIANT STUDY IS THE FIRST CONTROLLED PHASE II TRIAL TO INVESTIGATE THE EFFICACY OF HUMAN NEURAL STEM CELLS FOR THE TREATMENT OF DRY AMD"